ag 3-5 has been researched along with neurotensin in 1 studies
| Studies (ag 3-5) | Trials (ag 3-5) | Recent Studies (post-2010) (ag 3-5) | Studies (neurotensin) | Trials (neurotensin) | Recent Studies (post-2010) (neurotensin) |
|---|---|---|---|---|---|
| 126 | 0 | 66 | 4,054 | 45 | 544 |
| Protein | Taxonomy | ag 3-5 (IC50) | neurotensin (IC50) |
|---|---|---|---|
| Neurotensin receptor type 1 | Homo sapiens (human) | 0.0013 | |
| Neurotensin receptor type 2 | Rattus norvegicus (Norway rat) | 0.0582 | |
| Sortilin | Homo sapiens (human) | 0.36 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giesecke, Y; Grötzinger, C; Hosokawa, H; Kaiser, S; Kobayashi, S; Langrehr, J; Mergler, S; Neuhaus, P; Neumann, M; Plath, T; Plöckinger, U; Strowski, MZ; Wiedenmann, B | 1 |
1 other study(ies) available for ag 3-5 and neurotensin
| Article | Year |
|---|---|
Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells.
Topics: Calcium; Humans; Membrane Potentials; Menthol; Models, Biological; Neuroendocrine Tumors; Neurotensin; Pancreatic Neoplasms; Pyrimidinones; TRPM Cation Channels; Tumor Cells, Cultured | 2007 |